Dr. Hugh Marston and Prof. dr. Martien Kas presented the PRISM project at the ECNP Innovation meeting, entitled “New approaches to psychiatric drug development”. At this meeting in Nice, PRISM was perceived as an exemplar project in which a paradigm shift is being introduced paving the road for acceleration of the neuropsychiatric drug discovery process.
Click here to view the meeting programme.
Major mental health project aims to uncover root causes of social withdrawal
A major European funding initiative aims to unpick the biological reasons underlying social withdrawal, which is a common early symptom of, Schizophrenia, Alzheimer’s disease and Major Depressive Disorder. The PRISM project (Psychiatric Ratings using Intermediate Stratified Markers), a €16.5m public-private cooperation, unites researchers from European academic centres, and major pharmaceutical companies.
